#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypophosphatasia Type IIa hyperlipidaemia Chorioretinitis Arrhythmia Short-bowel syndrome Nephrotic syndrome Aspergillus infection Congenital growth hormone deficiency Chronic graft versus host disease in liver Chronic lymphocytic leukaemia recurrent Pustular psoriasis Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Chronic lymphocytic leukaemia Glomerulonephritis Eosinophilic granulomatosis with polyangiitis More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis Cystic fibrosis lung – Diagnostics Pelizaeus-Merzbacher disease – Life with Disease Synovial sarcoma recurrent – Life with Disease Congenital hypotransferrinaemia – Life with Disease Mucopolysaccharidosis II – Life with Disease Factor VIII deficiency – Treatment Glycogen storage disease type V – Basic Information Ewing’s sarcoma metastatic – Life with Disease Andersen-Tawil syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IHMA-2121771-1 Protrans Sulodexide Rbl027.2 Bms-986435 Tasquinimod Tipiracil Hydrochloride Tomligisiran Cenobamate Pemigatinib Mbf-118 Paracetamol Valiltramiprosate Mps-106 Dermatophagoides Farinae Blood And Related Products GOLD SODIUM THIOSULFATE Alxn2220 Lorazepam Canagliflozin More therapies…

    Learn about Your Condition

    Small intestine carcinoma Small intestine leiomyosarcoma Juvenile idiopathic arthritis Hip fracture Ocular melanoma Metastases to rectum Haemodynamic instability Naevus flammeus Juvenile absence epilepsy Atrial septal defect Papulopustular rosacea Fibrous dysplasia of bone Skin candida Carotid artery stenosis Soft tissue sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. MENTUM, s.r.o.

MENTUM, s.r.o.

Ruzinovska 10, Bratislava, 820 07, Slovakia

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

    Recruiting

    2 1 1
    Bulgaria Czechia Germany Hungary Poland Romania +1

  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

    Recruiting

    2 1
    Investigated Drugs:
    • Iti-1284
    Bulgaria Czechia Finland Poland Slovakia

  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Valbenazine Ditosylate
    Czechia Germany Italy Romania Slovakia Spain

  • Study on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder

    Not recruiting

    4 1
    Investigated Diseases:
    • Generalised anxiety disorder
    Investigated Drugs:
    • Ulotaront
    Bulgaria Estonia Finland Slovakia Spain Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!